LEADER 02891nam  2200613 a 450 
001 9910962333503321
005 20200520144314.0
010   $a9781608054749
010   $a1608054748
035   $a(CKB)2550000001040967
035   $a(EBL)1121697
035   $a(OCoLC)827207354
035   $a(SSID)ssj0001355734
035   $a(PQKBManifestationID)11813787
035   $a(PQKBTitleCode)TC0001355734
035   $a(PQKBWorkID)11348074
035   $a(PQKB)10207318
035   $a(MiAaPQ)EBC1121697
035   $a(DE-B1597)732002
035   $a(DE-B1597)9781608054749
035   $a(Perlego)976737
035   $a(EXLCZ)992550000001040967
100   $a20130226d2013      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAdvances in cancer drug targets$hVolume 1 /$feditor, Atta-ur-Rahman
205   $a1st ed.
210   $aSharjah, United Arab Emirates ;$aOak Park, Ill. $cBentham Science Publishers$d[2013?]
215   $a1 online resource (316 p.)
225 0 $aAdvances in cancer drug targets,$x2213-9915 ;$vv. 1
300   $aDescription based upon print version of record.
311 08$a9781608056019 
311 08$a1608056015 
320   $aIncludes bibliographical references and index.
327   $aTitle; EUL; Contents; Foreword; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Index
330   $aAdvances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA. The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.
410  0$aAdvances in Cancer Drug Targets
606   $aCancer$xChemotherapy
606   $aDrug targeting
615  0$aCancer$xChemotherapy.
615  0$aDrug targeting.
676   $a615/.19
700   $aRahman$b Atta-ur, $4aut$4http://id.loc.gov/vocabulary/relators/aut$0544456
701   $aRahman$b Atta-ur-$f1942-$0544456
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910962333503321
996   $aAdvances in cancer drug targets$94345117
997   $aUNINA